
Fueled In Part By The Opioid Epidemic, The Number Of Reported Hepatitis C Virus Infections Tripled In The United States Between 2010 And 2015. As New Infections Continue To Mount, New Therapies Have Produced Seismic Changes In How Hcv Is Treated Clinically, Leaving A Gap Between The Most Current Clinical Guidance And The Ongoing Demands Of Patient Care. The New Hepatitis C Is A Current And Essential Review Of Hcv's Epidemiology, Diagnosis, And Clinical Approaches -- A Clinician's Guidebook For Navigating Everything From Screening To Treatment. Acute And Chronic Hcv Are Addressed, As Are Important New Treatment Options For Hcv, Management Of Side Effects, And A Convenient Summary Of Clinical Trials On The Treatment Of Chronic Hepatitis C. Updated To Detail The Standards Of Care That Will Define The Next Decade Of Hcv Management, This Evidence-based Volume Is An Essential Clinical Reference For To Any Practitioner In Gastroenterology, Hepatology, Infectious Disease, Transplant, Or Internal Medicine.
This text investigates the clinical challenges and evolving treatment paradigms for Hepatitis C in the wake of rising infection rates linked to the opioid epidemic. Authors Donald M. Jensen and Nancy Reau, both established experts in hepatology, synthesize current epidemiological data and pharmacological advancements to provide a standardized framework for patient care. The volume bridges the gap between emerging clinical research and the practical demands of daily medical practice.
What You Will Find
Scope Limits
Medical professionals identify this work as a primary reference for practitioners in gastroenterology and infectious disease. Experts highlight the text for its focus on evidence-based standards that define current clinical practice.
Page Count:
240
Publication Date:
2018-01-01
Publisher:
Oxford University Press
ISBN-10:
0190238291
ISBN-13:
9780190238292
No comments yet. Be the first to share your thoughts!